Kenneth G. Saag

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

Josef S Smolen, Robert Landewé, J. W. J. Bijlsma et al. · Annals of the Rheumatic Diseases · 2020 · 2.8K citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine

Nicole C. Wright, Anne C. Looker, Kenneth G. Saag et al. · Journal of Bone and Mineral Research · 2014 · 1.8K citations · Full text

Medicine, Geriatric Medicine, Population Health Sciences +15

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis

Kenneth G. Saag, Gim Gee Teng, Nivedita M. Patkar et al. · Arthritis Care & Research · 2008 · 1.5K citations

Medicine, Pharmacotherapy, Clinical Medicine +11

Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis

Kenneth G. Saag, Jeffrey Petersen, Maria Luisa Brandi et al. · New England Journal of Medicine · 2017 · 1.5K citations · Full text

Medicine, Orthopedic Surgery, Bone Augmentation +16

The clinician’s guide to prevention and treatment of osteoporosis

Meryl S. LeBoff, S. L. Greenspan, Karl Insogna et al. · Osteoporosis International · 2022 · 1.3K citations · Full text

Medicine, Internal Medicine, Orthopedic Surgery +17